Home » Topics » BioWorld Science

BioWorld Science
RSS

New selective dopamine D4 complete antagonist reported

Aug. 10, 2001

Osteoarthritis product launched in Europe

Aug. 10, 2001

Theratechnologies submits IND application to Health Canada for ThGRF1-44

Aug. 10, 2001

Final results of PH-10 pilot study in the treatment of plaque psoriasis reported

Aug. 10, 2001

Preliminary animal studies indicate that Oxycyte may be safer than other PFC emulsions

Aug. 10, 2001

Companies form strategic agreement to develop asthma and allergic rhinitis products

Aug. 10, 2001

Dual PPAR agonist shows good preclinical results

Aug. 10, 2001

Incara's porphyrin-based catalytic antioxidant is neuroprotective in ischemia

Aug. 10, 2001

Smooth muscle-relaxing agents reported by Kissei

Aug. 9, 2001

Kyowa Hakko patents new compounds for treatment of urinary incontinence

Aug. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...